*** Disclaimer: This Database is still undergoing update on daily basis to prevent errors, discrepancies, and missing records. Please Contact FDIC@nafdac.gov.ng for enquires ***

Product Details

CO-APROVEL 300/12.5 MG TABLET

Irbesartan; Hydrochlorothiazide
300 mg; 12.5 mg
Tablet

ROA

Oral

Applicant Name

Sanofi-Aventis Nigeria Limited

NRN

A4-8166

Status

Active


ATC Code

C09DA04  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

2X14  

Product Description

27 RNW-PP-296725 CO-APROVEL 300/12.5 MG TABLET IRBESARTAN 300MG + HYDROCHLOROTHIAZIDE 12.5MG IRBESARTAN 300MG + HYDROCHLOROTHIAZIDE 12.5MG A4-8166 Drugs Imported Products 2X14 POM 1 11/29/2022 SANOFI-AVENTIS NIGERIA LIMITED, JAPAUL HOUSE, DR.NURUDEEN OLOWOPOPO AVENUE IKEJA LAGOS 08174600446; 012710135 hilda.nwabudike@sanofi.com SANOFI WINTHROP INDUSTRIE, , 1 RUE DE LA VIERGE, AMBARES ET LAGRAVE, 33565 CARBON-BLANC-CEDEX, FRANCE, France

Manufacturer Name

Sanofi Winthrop Industrie

Manufacturer Country

FRANCE  

Approval Date

2023-05-25  

Expiry Date

2028-05-24